B Cell Depletion With an Anti-CD20 Antibody Enhances Alloreactive Memory T Cell Responses After Transplantation

Area of Science:

• Immunology
• Transplantation Science
• T Cell Biology

Background:

• Alloreactive memory T cells drive rapid allograft rejection and hinder transplant tolerance.
• B cell deficiency impairs memory T cell responses post-transplantation.
• Previous studies show anti-CD20 antibody (rituximab) with cyclosporine A improves islet allograft survival in non-human primates.

Purpose of the Study:

• To investigate the impact of anti-CD20 antibody-mediated B cell depletion on T cell alloresponses in mice.
• To determine if B cell depletion affects direct and indirect alloresponses.
• To assess the effect of B cell depletion on memory T cell reactivation and allograft rejection.

Main Methods:

• Treatment of wild-type and transgenic mice with an IgG2a anti-CD20 monoclonal antibody for B cell depletion.
• Assessment of direct and indirect alloresponses after skin transplantation in naive mice.
• Evaluation of allospecific memory T cell reactivation and second-set allograft rejection in sensitized mice.

Main Results:

• B cell depletion did not alter the direct alloresponse.
• A significant increase in the indirect alloresponse was observed after B cell depletion in naive mice.
• Anti-CD20 treatment enhanced memory T cell reactivation and accelerated second-set skin allograft rejection in sensitized mice.

Conclusions:

• The effects of anti-CD20 antibodies on alloimmunity and allograft rejection are complex.
• Outcomes may depend on the specific antibody used and the clinical context.
• B cell depletion can have differential effects on T cell alloresponses, potentially exacerbating rejection in certain scenarios.